Olr1020 Activators
Chemical activators of Olr1020 operate through a consistent molecular mechanism that hinges on the modulation of cyclic AMP (cAMP) levels and subsequent activation of protein kinase A (PKA). Forskolin serves as a direct activator of adenylyl cyclase, an enzyme that catalyzes the conversion of ATP to cAMP. The increase in cAMP within the cell then leads to the activation of PKA, which in turn phosphorylates Olr1020, leading to its functional activation. Similarly, Isoproterenol, a beta-adrenergic agonist, binds to beta-adrenergic receptors, stimulating adenylyl cyclase to increase cAMP and subsequently activate PKA. The PKA then phosphorylates Olr1020. Prostaglandin E2 (PGE2) operates through its specific G protein-coupled receptors (GPCRs) to activate adenylyl cyclase, again raising cAMP levels and engaging PKA to phosphorylate Olr1020.
Further, IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP, thus sustaining PKA activation and the phosphorylation state of Olr1020. Epinephrine binds to adrenergic receptors and triggers a similar cascade, resulting in PKA-mediated phosphorylation of Olr1020. Dopamine activates D1-like receptors that are coupled to adenylyl cyclase, leading to the same downstream effects on Olr1020. Histamine, through its action on H2 receptors, and adenosine, through A2A or A2B receptors, both stimulate adenylyl cyclase, thereby promoting the activation of PKA and subsequent phosphorylation of Olr1020. Glucagon's interaction with its receptor, Terbutaline's and Salbutamol's activation of beta-2 adrenergic receptors, and Rolipram's inhibition of PDE4, all ultimately enhance PKA activity, ensuring that Olr1020 is phosphorylated and activated. Each of these chemicals, despite having distinct initial targets or mechanisms, converge on the common pathway involving cAMP and PKA to modulate the activity of Olr1020.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can activate adrenergic receptors, stimulating adenylyl cyclase, and increasing intracellular cAMP levels. Elevated cAMP activates PKA, which could then phosphorylate and activate Olr1020. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G protein-coupled receptors (GPCRs), leading to the activation of adenylyl cyclase and increased cAMP production. This cascade can result in the activation of PKA, which may phosphorylate and activate Olr1020. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, thereby enhancing its accumulation. Higher cAMP levels promote PKA activation, which can phosphorylate and activate Olr1020. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to and activates adrenergic receptors, inducing adenylyl cyclase activation, cAMP accumulation, and subsequent PKA activation. This signal transduction can lead to the phosphorylation and activation of Olr1020. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can activate dopaminergic receptors, particularly D1-like receptors, which are coupled to adenylyl cyclase activation, resulting in increased cAMP and PKA activation. PKA can catalyze the phosphorylation and activation of Olr1020. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine may bind to H2 receptors, which are GPCRs that stimulate adenylyl cyclase activity, increasing cAMP levels and leading to PKA activation. PKA then has the potential to phosphorylate and activate Olr1020. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine can activate A2A or A2B receptors, which are linked to adenylyl cyclase activation, resulting in elevated cAMP and PKA activation. PKA phosphorylation can activate Olr1020. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta-2 adrenergic agonist that can stimulate adenylyl cyclase via its receptor, increasing cAMP levels and activating PKA. PKA can then phosphorylate and activate Olr1020. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. Inhibition of PDE4 leads to increased cAMP levels, thereby enhancing PKA activation. PKA can phosphorylate and activate Olr1020. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a beta-2 adrenergic receptor agonist that induces adenylyl cyclase activity, leading to increased cAMP and PKA activation. PKA can phosphorylate and activate Olr1020. | ||||||